Anti-viral effect of usenamine a using SARS-CoV-2 pseudo-typed viruses

被引：1
|
作者：
Li, Zijun [1 ,2 ]
Lee, Joo-Eun [2 ]
Cho, Namki [2 ]
Yoo, Hee Min [1 ,3 ]
机构：
[1] Korea Res Inst Stand & Sci KRISS, Biometrol Grp, Daejeon 34113, South Korea
[2] Chonnam Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, Gwangju 61186, South Korea
[3] Univ Sci & Technol UST, Dept Precis Measurement, Daejeon 34113, South Korea
来源：
HELIYON | 2023年 / 9卷 / 11期
基金：
新加坡国家研究基金会;
关键词：
Natural products; SARS-CoV-2; Pseudotyped viruses; Antiviral activity; Reactive oxygen species; USNIC ACID; HOSPITALIZED-PATIENTS; USNEA-BARBATA; IN-VITRO; TOCILIZUMAB; ANTIFUNGAL; EXTRACTS;
D O I：
10.1016/j.heliyon.2023.e21742
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
The escalating pandemic brought about by the novel SARS-CoV-2 virus is threatening global health, and thus, it is necessary to develop effective antiviral drugs. Usenamine A is a dibenzofuran derivative separated from lichen Usnea diffracta showing broad-spectrum activity against different viruses. We evaluate that usenamine A has antiviral effects against novel SARS-CoV-2 Delta variant pseudotyped viruses (PVs) in A549 cells. In addition, usenamine A significantly suppresses SARS-CoV-2 PV-induced mitochondrial depolarization, elevated reactive oxygen species (ROS) levels, apoptosis, and inflammation. Usenamine A also causes the SARS-CoV-2 spike protein to become less stable. Thus, usenamine A shows potential as an antiviral drug that can provide protection against COVID-19.
引用
收藏
页数：14
相关论文
共 50 条
  • [31] Gramicidin S and melittin: potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection
    Enayathullah, Mohammed Ghalib
    Parekh, Yash
    Banu, Sarena
    Ram, Sushma
    Nagaraj, Ramakrishnan
    Kumar, Bokara Kiran
    Idris, Mohammed M.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [32] In vitro screening of anti-viral and virucidal effects against SARS-CoV-2 by Hypericum perforatum and Echinacea
    Bajrai, Leena Hussein
    El-Kafrawy, Sherif Ali
    Hassan, Ahmed Mohamed
    Tolah, Ahmed Majdi
    Alnahas, Rabie Saleh
    Sohrab, Sayed Sartaj
    Rehan, Mohd
    Azhar, Esam Ibraheem
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [33] In vitro screening of anti-viral and virucidal effects against SARS-CoV-2 by Hypericum perforatum and Echinacea
    Leena Hussein Bajrai
    Sherif Ali El-Kafrawy
    Ahmed Mohamed Hassan
    Ahmed Majdi Tolah
    Rabie Saleh Alnahas
    Sayed Sartaj Sohrab
    Mohd Rehan
    Esam Ibraheem Azhar
    Scientific Reports, 12
  • [34] From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
    Rakedzon, S.
    Neuberger, A.
    Domb, A. J.
    Petersiel, N.
    Schwartz, E.
    JOURNAL OF TRAVEL MEDICINE, 2021, 28 (02)
  • [35] Could boron-containing compounds (BCCs) be effective against SARS-CoV-2 as anti-viral agent?
    Cetiner, E.
    Sayin, K.
    Tuzun, B.
    Ataseven, H.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2021, 122 (04): : 263 - 269
  • [36] Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2
    Chan, Yi-Hao
    Fong, Siew-Wai
    Poh, Chek-Meng
    Carissimo, Guillaume
    Yeo, Nicholas Kim-Wah
    Amrun, Siti Naqiah
    Goh, Yun Shan
    Lim, Jackwee
    Xu, Weili
    Chee, Rhonda Sin-Ling
    Torres-Ruesta, Anthony
    Lee, Cheryl Yi-Pin
    Tay, Matthew Zirui
    Chang, Zi Wei
    Lee, Wen-Hsin
    Wang, Bei
    Tan, Seow-Yen
    Kalimuddin, Shirin
    Young, Barnaby Edward
    Leo, Yee-Sin
    Wang, Cheng-, I
    Lee, Bernett
    Rotzschke, Olaf
    Lye, David Chien
    Renia, Laurent
    Ng, Lisa F. P.
    EMBO MOLECULAR MEDICINE, 2021, 13 (06)
  • [37] DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action
    Iaconis, Daniela
    Caccuri, Francesca
    Manelfi, Candida
    Talarico, Carmine
    Bugatti, Antonella
    Filippini, Federica
    Zani, Alberto
    Novelli, Rubina
    Kuzikov, Maria
    Ellinger, Bernhard
    Gribbon, Philip
    Riecken, Kristoffer
    Esposito, Francesca
    Corona, Angela
    Tramontano, Enzo
    Beccari, Andrea Rosario
    Caruso, Arnaldo
    Allegretti, Marcello
    VIRUSES-BASEL, 2023, 15 (05):
  • [38] Evaluation of the Anti-Viral Activity of Human Recombinant Interferon Lambda-1 against SARS-CoV-2
    Madonov, P. G.
    Svyatchenko, V. A.
    Legostaev, S. S.
    Kikhtenko, N. A.
    Kotlyarova, A. A.
    Oleinik, L. A.
    Baikalov, G., I
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2021, 172 (01) : 53 - 56
  • [39] Cell Type-Specific Anti-Viral Effects of Novel SARS-CoV-2 Main Protease Inhibitors
    Geiger, Nina
    Diesendorf, Viktoria
    Roll, Valeria
    Koenig, Eva-Maria
    Obernolte, Helena
    Sewald, Katherina
    Breidenbach, Julian
    Pillaiyar, Thanigaimalai
    Guetschow, Michael
    Mueller, Christa E.
    Bodem, Jochen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
  • [40] Evaluation of the Anti-Viral Activity of Human Recombinant Interferon Lambda-1 against SARS-CoV-2
    P. G. Madonov
    V. A. Svyatchenko
    S. S. Legostaev
    N. A. Kikhtenko
    A. A. Kotlyarova
    L. A. Oleinik
    G. I. Baikalov
    Bulletin of Experimental Biology and Medicine, 2021, 172 : 53 - 56
12345